Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
50.55    0.00 (0.00%)
Bid:
49.60
Ask:
51.50
Spread: 1.90 (3.831%)
Market Cap: £193.32m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

Interim Management Statement

19 May 2009 13:36

RNS Number : 5073S
British SmallerTechCompaniesVCT2PLC
19 May 2009
 



BRITISH SMALLER TECHNOLOGY COMPANIES VCT 2 PLC ("the Company")

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 March 2009

British Smaller Technology Companies VCT 2 plc presents its interim management statement for the quarter ended 31 March 2009. This constitutes the Company's first interim management statement for the financial year ending 31 December 2009, as required by Rule 4.3 of the Disclosure and Transparency Rules. A copy of this interim management statement can be found at www.yfmgroup.co.uk.

The unaudited net asset value per Ordinary share as at 31 March 2009 was 75.7p (31 December 2008: 76.9p). The net asset value as at 31 March 2009 is stated after taking account of the third interim dividend of 2.0p per Ordinary share in respect of the year ended 31 December 2008, which will be paid on 19 May 2009.

The total return at 31 March 2009, calculated by reference to the net asset value per share and the cumulative dividends paid and proposed, was 93.7p per share compared to 92.9p at 31 December 2008.

The number of Ordinary shares in issue at 31 March 2009 was 16,641,257. There were no shares purchased or issued by the Company during the quarter.

Net assets at 31 March 2009 comprised the following:

£000

% of net assets

Unquoted investments at fair value

6,493

51.5%

Quoted investment at bid price

1,178

9.4%

Gilt investments

4,313

34.2%

Total investments

11,984

95.1%

Cash and cash equivalents

634

5.0%

Other net current assets (liabilities)

(16)

(0.1%)

Net assets

12,602

100.0%

The ten largest investments by valuation at 31 March 2009 were as follows:

£000

% of net assets

Digital Healthcare Limited

2,112

16.8%

Silistix Limited

895 

7.1%

Immunobiology Limited

800 

6.3%

DxS Limited

792 

6.3%

Primal Pictures Limited

716 

5.7%

The ART Technology Group Inc

456 

3.6%

Pressure Technologies plc

350 

2.8%

Waterfall Services Limited

316 

2.5%

Ellfin Home Care Limited

312

2.4%

Harvey Jones Limited

247 

2.0%

Top ten investments

6,996

55.5%

Other investments

675

5.4%

Gilt investments

4,313

34.2%

Total investments

11,984

95.1%

Quoted investments are carried at bid price at 31 March 2009. Unquoted investment are carried at fair value as at 31 March 2009 as determined by the directors.

The movement in net asset value can be analysed as: 

Pence 

per share

NAV at 31.12.08

76.9

Less Dividend

(2.0) 

Change in underlying NAV

0.8

NAV at 31.03.09

75.7

The total return, calculated by reference to the net asset value plus cumulative dividend paid and proposed has increased by 0.8p to 93.7p, cumulative dividends representing 18 pence per share, the equivalent of 19.2%.

The net asset value currently comprises 39% in cash and gilts and as such the Company is well placed to take advantage of selective investment opportunities as they arise.

19 May 2009

For further information please contact:

David Hall YFM Private Equity Tel: 0161 832 7603

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGUUCWAUPBGPB
Date   Source Headline
23rd Sep 201910:10 amRNSPayment of Dividend and Issue of Equity
14th Aug 20199:14 amRNSHalf-year Report
10th May 20199:43 amRNSPayment of Final Dividend and Issue of Equity
7th May 20192:18 pmRNSResult of AGM and Change of Chairman
7th May 20199:53 amRNSInterim Management Statement
4th Apr 201912:13 pmRNSDirector/PDMR Shareholding
4th Apr 201912:13 pmRNSDirector/PDMR Shareholding
4th Apr 201912:11 pmRNSDirector/PDMR Shareholding
4th Apr 201912:10 pmRNSDirector/PDMR Shareholding
1st Apr 20193:51 pmRNSIssue of Equity
1st Apr 20193:44 pmRNSIssue of Equity and Close of Offers
27th Mar 201910:19 amRNSTransaction in Own Shares and Net Asset Value
26th Mar 20194:29 pmRNSPublication of Supplementary Prospectus
26th Mar 20194:27 pmRNSPublication of Supplementary Prospectus
22nd Mar 201911:48 amRNSAnnual Financial Report
6th Mar 201911:09 amRNSAppointment of non-executive director
15th Feb 20199:56 amRNSPayment of interim dividend and issue of shares
11th Feb 201911:15 amRNSClose of Offers to New Applications
11th Feb 201911:15 amRNSClose of Offers to New Applications
28th Jan 20193:00 pmRNSUtilisation of over-allotment facility
28th Jan 20193:00 pmRNSUtilisation of over-allotment facility
7th Jan 20192:15 pmRNSDividend Declaration
7th Jan 20191:15 pmRNSStatement re Prospectus
7th Jan 20191:15 pmRNSStatement re Prospectus
21st Dec 20189:13 amRNSDisposal
20th Dec 201810:20 amRNSTransaction in Own Shares
27th Nov 20186:07 pmRNSPublication of Prospectus
27th Nov 20185:49 pmRNSPublication of Prospectus
21st Nov 20181:00 pmRNSUnaudited Interim Results to 30 September 2018
23rd Oct 20181:00 pmRNSStatement re proposed joint fundraising
23rd Oct 20181:00 pmRNSStatement re proposed joint fundraising
28th Sep 20189:54 amRNSPayment of dividend and allotment of shares
27th Sep 20181:27 pmRNSTransaction in Own Shares
17th Aug 20188:07 amRNSHalf-year Report
25th Jun 201811:52 amRNSTransaction in Own Shares
11th May 201810:01 amRNSPayment of final dividend and allotment of shares
9th May 20182:36 pmRNSResult of Annual General meeting
9th May 20189:54 amRNSInterim Management Statement
28th Mar 20188:27 amRNSTransaction in Own Shares
16th Mar 20181:43 pmRNSAnnual Financial Report
16th Feb 20189:50 amRNSIssue of Equity
12th Feb 201810:50 amRNSDirector Declaration
26th Jan 20189:24 amRNSClose of Offer to New Subscriptions
11th Jan 20188:06 amRNSOffer for Subscription
20th Dec 20178:50 amRNSPurchase of own securities and total voting rights
20th Dec 20178:50 amRNSLaunch of Top-up Offer
30th Nov 20171:28 pmRNSInterim Management Statement to 30 September 2017
20th Oct 20172:12 pmRNSTransaction in Own Shares
29th Sep 20179:47 amRNSPayment of interim dividend and issue of shares
29th Sep 20179:36 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.